Home Applications 078893 Application 078893
Type ANDA
Sponsor MYLAN Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 CARBIDOPA AND LEVODOPA CARBIDOPA; LEVODOPA TABLET, ORALLY DISINTEGRATING;ORAL 10MG;100MG No No 002 CARBIDOPA AND LEVODOPA CARBIDOPA; LEVODOPA TABLET, ORALLY DISINTEGRATING;ORAL 25MG;100MG No No 003 CARBIDOPA AND LEVODOPA CARBIDOPA; LEVODOPA TABLET, ORALLY DISINTEGRATING;ORAL 25MG;250MG No Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A078893-001 CARBIDOPA AND LEVODOPA CARBIDOPA; LEVODOPA 10MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2008-09-18 A078893-002 CARBIDOPA AND LEVODOPA CARBIDOPA; LEVODOPA 25MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2008-09-18 A078893-003 CARBIDOPA AND LEVODOPA CARBIDOPA; LEVODOPA 25MG;250MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2008-09-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 4 of 4 · 135 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A078893-001 CARBIDOPA AND LEVODOPA 10MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A078893-002 CARBIDOPA AND LEVODOPA 25MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A078893-003 CARBIDOPA AND LEVODOPA 25MG;250MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A078893-001 CARBIDOPA AND LEVODOPA 10MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A078893-002 CARBIDOPA AND LEVODOPA 25MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 A078893-003 CARBIDOPA AND LEVODOPA 25MG;250MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A078893-001 CARBIDOPA AND LEVODOPA 10MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 e64feba35796…2022-09-29 23:25 UTC 2022-09 A078893-002 CARBIDOPA AND LEVODOPA 25MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 e64feba35796…2022-09-29 23:25 UTC 2022-09 A078893-003 CARBIDOPA AND LEVODOPA 25MG;250MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A078893-001 CARBIDOPA AND LEVODOPA 10MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A078893-002 CARBIDOPA AND LEVODOPA 25MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A078893-003 CARBIDOPA AND LEVODOPA 25MG;250MG TABLET, ORALLY DISINTEGRATING / ORAL 2008-09-18 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A078893-001 CARBIDOPA AND LEVODOPA 10MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2008-09-18 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A078893-002 CARBIDOPA AND LEVODOPA 25MG;100MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2008-09-18 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A078893-003 CARBIDOPA AND LEVODOPA 25MG;250MG TABLET, ORALLY DISINTEGRATING / ORAL AB 2008-09-18 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 45 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 3 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0378-5051 Carbidopa and Levodopa carbidopa and levodopa Mylan Pharmaceuticals Inc. ANDA Current 0378-5052 Carbidopa and Levodopa carbidopa and levodopa Mylan Pharmaceuticals Inc. ANDA Current 0378-5053 Carbidopa and Levodopa carbidopa and levodopa Mylan Pharmaceuticals Inc. ANDA Current